$IVOB Could Become a Crowd Favorite in the UK
October 9th, 2009 at 6:16 am Posted by
An article this morning suggests that some causes of infertility such as STDs and exposure to plastics and other environmental toxins is preventable. The article from the American Family Association (AFA) suggests that chlamydia, which has been linked to infertility, accounts for more than 1.1 million STD cases every year.
The article also points out that 7.3 million American women are facing some type of problem with infertility. Surprisingly to many, this number is considerably low when compared to infertile populations in countries like China and the UK.
The Dean has taught the CollegeStock Community recently that infertility affects up to 20% of the female population in China. And recent news suggests that British couples might also account for a large number of couples seeking treatment with an infertility rate of 14%.
An article from earlier this month suggests that medical conditions are responsible for many of the difficulties experienced by at least 3.5 million in western England. With such a high rate of infertility, it almost comes as no surprise that statistics from the Human Fertilisation and Embryology Authority (HFEA) show that of 1.4% all births and 1.7% of all babies in the UK were the result of IVF treatments.
The article from the British Fertility Society suggested that couples trying to conceive later on in life contributes to this large number of infertile couples. However, the source also makes it clear that “older women having babies has, in many cases, been made possible by IVF treatment.”
The Dean believes there’s great potential for $IVOB‘s INVOcell device in parts of England for several reasons. One of these reasons is that $IVOB‘s INVOcell has received CE Mark approval, which is equivalent to FDA approval in countries like England. The Dean feels this also makes $IVOB‘s device and procedure more available, while funding for up to 6 IVF cycles in some areas also makes $IVOB‘s INVO procedure a cost-effective and desirable IVF treatment for millions of infertile couples and the government.
According to figures releases by HFEA, the number of women undergoing IVF treatment has been rising. The report revelas that 38,861 women received IVF in 2007 compared to 34,855 in 2006—an increase of 5.8%. The number of IVF treatment applications, or cycles, also increased by nearly 6% and the number of IVF births rose to 8.3%, during the same period of time.
The Dean knows that the embryo mix-up in Ohio last month shed a negative spotlights on IVF—and not just in the United States. A report this week in the UK showed that 182 incidents were reported out of 52,000 cycles of treatment. HFEA considers “serious mix-ups” as Grade A and reported 8 such instances between 2007-2008.
Since many of these so-called mix-ups involve inserting the wrong embryo into the infertile patient, The Dean believes $IVOB‘s INVO procedure, which doesn’t require for the storage of embryos, could become a crowd favorite all over the world.
